Drug Type siRNA |
Synonyms- |
Target |
Mechanism CYP3A5 inhibitors(cytochrome P450 family 3 subfamily A member 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | 15 Jun 2022 |